Services-Commercial Physical & Biological Research
Standard Industrial Classification: SIC 8731
Industry Insider Sentiment Analysis
The Services-Commercial Physical & Biological Research sector (SIC 8731) acts as a critical barometer for broader economic health. Our real-time monitoring reveals 2487 total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-07 23:44 | 2025-07-02 | INCY | INCYTE CORP | Denton Sheila A. | Officer | OPT+S | $68.61 | 599 | $41,097 | 26,504 |
| 2025-07-07 23:43 | 2025-07-03 | INCY | INCYTE CORP | Iyengar Vijay K | Officer | SELL | $68.15 | 8,617 | $587,275 | 37,701 |
| 2025-07-03 23:30 | 2025-07-01 | NOTV | Inotiv, Inc. | Neff R Matthew | Director | SELL | $1.81 | 2,000 | $3,621 | 151,102 |
| 2025-06-05 23:04 | 2025-06-03 | INCY | INCYTE CORP | Denton Sheila A. | Officer | OPT+S | $68.00 | 1,795 | $122,060 | 26,504 |
| 2025-06-04 23:05 | 2025-06-02 | NOTV | Inotiv, Inc. | Neff R Matthew | Director | SELL | $2.62 | 2,000 | $5,246 | 153,102 |
| 2025-06-03 23:00 | 2025-05-30 | INCY | INCYTE CORP | Tray Thomas | Officer | SELL | $65.38 | 1,614 | $105,516 | 22,003 |
| 2025-05-16 23:29 | 2025-05-15 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | MASSARO GEORGE | Director | SELL | $137.57 | 140 | $19,260 | 5,575 |
| 2025-05-15 23:41 | 2025-05-14 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | MASSARO GEORGE | Director | SELL | $140.74 | 140 | $19,703 | 5,715 |
| 2025-05-15 23:38 | 2025-05-13 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | Officer | SELL | $145.41 | 500 | $72,705 | 19,513 |
| 2025-05-15 23:02 | 2025-05-15 | OABI | OmniAb, Inc. | Cochran Jennifer R. | Director | BUY | $1.52 | 30,000 | $45,600 | 145,274 |
| 2025-05-15 00:04 | 2025-05-14 | OABI | OmniAb, Inc. | Love Steven | Director | BUY | $1.46 | 25,000 | $36,500 | 38,333 |
| 2025-05-14 00:52 | 2025-05-12 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Director | BUY | $1.44 | 65,000 | $93,600 | 2,831,887 |
| 2025-05-13 18:30 | 2025-05-12 | NRC | NATIONAL RESEARCH CORP | BEANS PATRICK E | 10% owner | BUY | $13.59 | 2,500 | $33,974 | 35,003 |
| 2025-04-28 23:39 | 2025-04-24 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Director | OPT+S | $301.82 | 1,712 | $516,716 | 2,998 |
| 2025-04-08 03:17 | 2025-04-07 | OABI | OmniAb, Inc. | FOEHR MATTHEW W | Director, Officer | OPT+S | $2.00 | 19,382 | $38,764 | 3,796,236 |
| 2025-04-08 03:10 | 2025-04-07 | OABI | OmniAb, Inc. | Berkman Charles S | Officer | OPT+S | $2.00 | 7,206 | $14,412 | 363,212 |
| 2025-04-08 03:09 | 2025-04-07 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | OPT+S | $2.00 | 7,206 | $14,412 | 223,828 |
| 2025-04-02 23:32 | 2025-04-01 | NOTV | Inotiv, Inc. | Coelho Mary Theresa | Director | SELL | $2.35 | 5,500 | $12,916 | 74,303 |
| 2025-04-02 03:43 | 2025-04-01 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | OPT+S | $2.37 | 11,963 | $28,352 | 217,492 |
| 2025-03-22 02:58 | 2025-03-21 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Director | BUY | $2.28 | 4,000 | $9,120 | 2,766,887 |
| 2025-03-21 03:15 | 2025-03-20 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Director | BUY | $2.35 | 125,750 | $295,513 | 2,762,887 |
| 2025-03-21 01:49 | 2025-03-18 | MXCT | MAXCYTE, INC. | Soleymannezhad Ali | Officer | SELL | $3.18 | 1,211 | $3,850 | 59,439 |
| 2025-03-21 01:47 | 2025-03-18 | MXCT | MAXCYTE, INC. | Sandoval David I. | Officer | SELL | $3.18 | 353 | $1,122 | 64,219 |
| 2025-03-21 01:08 | 2025-03-18 | MXCT | MAXCYTE, INC. | Swirsky Douglas J | Officer | SELL | $3.18 | 6,939 | $22,061 | 111,811 |
| 2025-03-18 23:01 | 2025-03-14 | INCY | INCYTE CORP | Flannelly Barry P | Officer | SELL | $67.69 | 19,807 | $1,340,657 | 33,567 |
| 2025-03-07 00:56 | 2025-03-04 | INCY | INCYTE CORP | Denton Sheila A. | Officer | OPT+S | $69.99 | 599 | $41,924 | 25,848 |
| 2025-03-01 02:34 | 2025-02-26 | INCY | INCYTE CORP | Denton Sheila A. | Officer | OPT+S | $74.07 | 14,069 | $1,042,136 | 25,848 |
| 2025-03-01 00:39 | 2025-02-27 | MEDP | Medpace Holdings, Inc. | EWALD STEPHEN P | Officer | BUY | $326.11 | 2 | $652 | 13,343 |
| 2025-02-27 00:18 | 2025-02-24 | MEDP | Medpace Holdings, Inc. | Carley Brian T | Director | OPT+S | $345.59 | 4,003 | $1,383,397 | 26,032 |
| 2025-02-22 00:41 | 2025-02-20 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FOSTER JAMES C | Director, Officer | BUY | $165.01 | 6,075 | $1,002,436 | 183,639 |
| 2025-02-22 00:38 | 2025-02-20 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Girshick Birgit | Officer | BUY | $164.63 | 1,514 | $249,250 | 55,058 |
| 2025-02-22 00:36 | 2025-02-20 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | Officer | SELL | $162.50 | 4,400 | $715,000 | 20,013 |
| 2025-02-21 00:34 | 2025-02-18 | NOTV | Inotiv, Inc. | Freeman Jeffrey Brennan | Officer | SELL | $4.05 | 1,339 | $5,416 | 27,478 |
| 2025-02-21 00:33 | 2025-02-18 | NOTV | Inotiv, Inc. | Taylor Beth | Officer | SELL | $4.01 | 4,370 | $17,507 | 108,368 |
| 2025-02-21 00:33 | 2025-02-18 | NOTV | Inotiv, Inc. | Sagartz John E | Director, Officer | SELL | $3.94 | 2,113 | $8,316 | 707,816 |
| 2025-02-21 00:32 | 2025-02-18 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Director, Officer | SELL | $3.82 | 73,617 | $281,136 | 956,592 |
| 2025-02-20 04:51 | 2025-02-19 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | OPT+S | $3.67 | 7,255 | $26,626 | 206,211 |
| 2025-02-20 04:51 | 2025-02-18 | OABI | OmniAb, Inc. | FOEHR MATTHEW W | Director, Officer | OPT+S | $3.67 | 33,486 | $123,034 | 3,779,160 |
| 2025-02-20 04:50 | 2025-02-18 | OABI | OmniAb, Inc. | Berkman Charles S | Officer | OPT+S | $3.68 | 15,470 | $56,857 | 356,876 |
| 2025-02-08 03:03 | 2024-12-03 | IQV | IQVIA HOLDINGS INC. | DANHAKL JOHN G | Director | BUY | $200.58 | 1,275 | $255,740 | 1,275 |
| 2025-02-05 00:15 | 2025-01-31 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Director, Officer | SELL | $4.15 | 22,700 | $94,298 | 1,030,209 |
| 2025-02-05 00:14 | 2025-01-31 | NOTV | Inotiv, Inc. | Taylor Beth | Officer | SELL | $4.47 | 2,054 | $9,171 | 112,738 |
| 2025-02-05 00:13 | 2025-01-31 | NOTV | Inotiv, Inc. | Sagartz John E | Director, Officer | SELL | $4.48 | 2,118 | $9,479 | 709,929 |
| 2025-02-05 00:12 | 2025-01-31 | NOTV | Inotiv, Inc. | Krupp Jeffrey Arthur | Officer | SELL | $4.42 | 2,508 | $11,096 | 28,557 |
| 2025-01-30 00:13 | 2025-01-27 | MXCT | MAXCYTE, INC. | Johnston John Joseph | Director | OPT+S | $4.65 | 3,000 | $13,935 | 141,950 |
| 2025-01-23 01:41 | 2025-01-21 | OABI | OmniAb, Inc. | Berkman Charles S | Officer | SELL | $3.24 | 25,489 | $82,584 | 343,190 |
| 2025-01-23 01:40 | 2025-01-21 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | SELL | $3.24 | 15,526 | $50,304 | 212,720 |
| 2025-01-23 01:40 | 2025-01-21 | OABI | OmniAb, Inc. | FOEHR MATTHEW W | Director, Officer | SELL | $3.24 | 41,811 | $135,468 | 3,749,639 |
| 2025-01-23 00:05 | 2025-01-21 | INCY | INCYTE CORP | Stein Steven H | Officer | SELL | $72.69 | 12,352 | $897,867 | 66,967 |
| 2025-01-15 00:03 | 2025-01-13 | MXCT | MAXCYTE, INC. | Sandoval David I. | Officer | SELL | $4.54 | 4,466 | $20,272 | 41,447 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Services-Commercial Physical & Biological Research sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8731) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Services-Commercial Physical & Biological Research
Every transaction in the Services-Commercial Physical & Biological Research industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.